Trial Profile
Compassionate Use of Metvix [Methyl aminolevulinate] PDT [photodynamic therapy] in Subjects With Field Actinic Keratoses, Large/Multiple Superficial BCCs [basal cell cancer], or Bowen's Disease
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 18 Feb 2021
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis; Basal cell cancer; Bowen's disease; Skin cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Sponsors Galderma
- 01 Nov 2007 New trial record.